발 및 발목용 기기 시장 기회, 성장 촉진요인, 산업 동향 분석 및 예측(2025-2034년)

The Global Foot and Ankle Devices Market was valued at USD 5.2 billion in 2024 and is estimated to grow at a CAGR of 7.3% to reach USD 10.6 billion by 2034. This substantial growth is driven by a rising number of sports-related injuries, a growing preference for minimally invasive and outpatient surgical procedures, technological advancements in device design, and an increasing incidence of orthopedic conditions. Chronic joint disorders such as osteoarthritis, rheumatoid arthritis, plantar fasciitis, and diabetic foot ulcers continue to affect a large population, especially aging adults, fueling demand for foot and ankle implants and braces. The surge in participation in professional and recreational sports among younger demographics also leads to a higher incidence of acute and overuse injuries, including ligament tears and fractures. Furthermore, trauma cases caused by falls and road accidents, particularly among older adults, contribute to the consistent demand for surgical interventions using plates, screws, and external fixators.

Foot and ankle devices are specially engineered medical tools aimed at treating, supporting, and managing injuries and conditions affecting the foot and ankle regions. These devices are essential for addressing a wide spectrum of issues, from acute trauma like fractures and ligament tears to chronic disorders such as arthritis, deformities, and tendon dysfunction. They include implants, braces, orthotics, and fixation systems that restore mobility, stability, and structural integrity. Whether used in surgical settings or for conservative treatment, these products help alleviate pain, improve gait, and prevent further damage.

The orthopedic implants segment generated USD 3.4 billion in 2024. These implants are essential for repairing fractures, correcting deformities, and addressing worn joints. The increase in road accidents and falls, especially among elderly individuals, continues to push the demand for orthopedic implants designed specifically for foot and ankle injuries. Additionally, patients suffering from arthritis often require total ankle or subtalar joint replacements. Advanced tools like pre-shaped locking plates, absorbable screws, and modular surgical kits enhance surgical accuracy and reduce the likelihood of revision surgeries. This segment's growth is further supported by the aging global population, which experiences higher rates of joint degeneration and fractures.

The trauma segment is projected to reach USD 4.2 billion by 2034. This segment's dominance stems from the rising frequency of trauma incidents caused by road traffic accidents, sports injuries, and other physical activities that result in fractures, dislocations, and ligament damage. Many trauma cases require immediate surgical care, where devices such as screws, plates, and external fixators are critical for stabilizing bones and restoring mobility. Older adults, vulnerable due to osteoporosis and balance issues, face higher risks of fractures from minor falls, while younger, active individuals involved in high-contact sports or physically demanding jobs add to the demand for trauma-related products. The growing adoption of implants made from advanced, durable materials is expected to drive market growth further.

U.S. Foot and Ankle Devices Market was valued at USD 2 billion in 2024. The country's substantial share is due to high rates of trauma and sports injuries, a well-developed healthcare infrastructure, and comprehensive insurance coverage for orthopedic treatments. The large populations of obese and diabetic individuals, prone to foot deformities and diabetic ulcers, increase the need for corrective surgeries. Moreover, the presence of prominent orthopedic manufacturers focusing on cutting-edge technologies like 3D-printed implants accelerates market development. The shift towards outpatient surgeries in ambulatory centers also boosts demand for both surgical and non-surgical foot and ankle care devices.

Key players in the Foot and Ankle Devices Industry include Acumed, Arthrex, DePuy Synthes (Johnson & Johnson), aap Implants Inc., Enovis, Medartis, Stryker, Smith+Nephew, Fillauer, Zimmer Biomet, Ottobock, CONMED, OSSUR, OrthoFix, VILEX, and ZIMMER BIOMET. Leading companies focus heavily on innovation, continuously developing new products that offer improved surgical outcomes and patient comfort. They invest in R&D to integrate advanced materials and technologies such as 3D printing and modular implant systems to meet diverse clinical needs. Strategic partnerships with healthcare providers and research institutions help facilitate product testing and market acceptance. Expanding geographic reach into emerging markets with growing healthcare infrastructure is also a priority to capture new demand. Companies enhance their competitive edge through acquisitions, enabling access to new technologies and product lines. Additionally, they emphasize education and training programs for surgeons to increase adoption rates.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product
  • 2.2.3 Application
  • 2.2.4 End Use
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Value addition at each stage
  • 3.1.3 Factor affecting the value chain
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of orthopedic disorders
    • 3.2.1.2 Rising incidence of trauma and road accidents
    • 3.2.1.3 Technological advancements in foot and ankle devices
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of foot and ankle devices
    • 3.2.2.2 Dearth of skilled healthcare professionals
  • 3.2.3 Opportunities
    • 3.2.3.1 Integration of digital health and smart orthotics
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Price trends, by product
• 3.7 Future market trends
• 3.8 Reimbursement scenario
  • 3.8.1 Impact of reimbursement policies on market growth
• 3.9 Consumer behaviour analysis
• 3.10 Gap analysis
• 3.11 Porter's analysis
• 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 Global
  • 4.2.2 North America
  • 4.2.3 Europe
  • 4.2.4 Rest of the world
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Orthopedic Implants and Devices
  • 5.2.1 Joint Implants
    • 5.2.1.1 Ankle Implants
    • 5.2.1.2 Other joint implants
  • 5.2.2 Fixation Devices
    • 5.2.2.1 Internal Fixation Devices
      • 5.2.2.1.1 Screws
      • 5.2.2.1.2 Plates
      • 5.2.2.1.3 Fusion nails
      • 5.2.2.1.4 Wires and pins
    • 5.2.2.2 External fixation devices
      • 5.2.2.2.1 Ring ankle fixators
      • 5.2.2.2.2 Other fixators
  • 5.2.3 Soft tissue orthopedic devices
• 5.3 Bracing and support devices
  • 5.3.1 Hinged braces and support devices
  • 5.3.2 Hard braces and support devices
  • 5.3.3 Soft bracing and support devices
• 5.4 Prostheses

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Trauma
• 6.3 Osteoarthritis
• 6.4 Hammertoe
• 6.5 Rheumatoid arthritis
• 6.6 Neurological disorders
• 6.7 Osteoporosis
• 6.8 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Orthopedic clinics
• 7.5 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 aap Implants Inc.
• 9.2 acumed
• 9.3 Arthrex
• 9.4 CONMED
• 9.5 DePuy Synthes (JnJ)
• 9.6 enovis
• 9.7 Fillauer
• 9.8 medartis
• 9.9 ORTHOFIX
• 9.10 OSSUR
• 9.11 ottobock
• 9.12 Smith+Nephew
• 9.13 stryker
• 9.14 VILEX
• 9.15 ZIMMER BIOMET